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A B S T R A C T
Orthogonal partial least squares regression (OPLS) is being increasingly adopted as an alternative to
partial least squares (PLS) regression due to the better generalization that can be achieved. Particularly in
multivariate batch statistical process control (BSPC), the use of OPLS for estimating nominal trajectories is
advantageous. In OPLS, the nominal process trajectories are expected to be captured in a single predictive
principal component while uncorrelated variations are ﬁltered out to orthogonal principal components.
In theory, OPLS will yield a better estimation of the Hotelling’s T2 statistic and corresponding control
limits thus lowering the number of false positives and false negatives when assessing the process
disturbances. Although OPLS advantages have been demonstrated in the context of regression, its use on
BSPC was seldom reported. This study proposes an OPLS-based approach for BSPC of a cocrystallization
process between hydrochlorothiazide and p-aminobenzoic acid monitored on-line with near infrared
spectroscopy and compares the fault detection performance with the same approach based on PLS. A
series of cocrystallization batches with imposed disturbances were used to test the ability to detect
abnormal situations by OPLS and PLS-based BSPC methods. Results demonstrated that OPLS was
generally superior in terms of sensibility and speciﬁcity in most situations. In some abnormal batches, it
was found that the imposed disturbances were only detected with OPLS.
© 2017 Elsevier B.V. All rights reserved.
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The industrial production of drug substances and dug products
is very often achieved as a sequence of batch operations (Van Impe
and Gins, 2015). Statistical process monitoring proposes a strategy
to detect deviations from normal process trajectories. It was ﬁrstly
developed for continuous processes operating in steady state (Van
Impe and Gins, 2015). Batch processes present challenges for
modelling and monitoring due to time changing dynamics,
variable duration, non-linear intrinsic nature and batch-to-batch
variability (Kourti, 2003; Van Impe and Gins, 2015). Latent variable
methods such as principal component analysis (PCA) and partial* Corresponding author.
E-mail address: jlopes@ff.ulisboa.pt (J.A. Lopes).
http://dx.doi.org/10.1016/j.ijpharm.2017.01.052
0378-5173/© 2017 Elsevier B.V. All rights reserved.least squares regression (PLS), applied in the context of batch
statistical monitoring, provide a possible way to overcome some of
the difﬁculties. To establish a multivariate batch statistical process
control (BSPC) scheme, PCA or PLS methods rely on batches
produced under normal operating conditions (NOC). A BSPC model
structure is optimized projecting unseen NOC and abnormal
batches. The goal is to ensure that the BSPC model can effectively
detect abnormal conditions in non-NOC batches (true positives)
while preventing NOC batches to be signaled as faulty batches
(false positives). Optimization of these models relies on multiple
factors: appropriate selection and pre-processing of process
variables, effective selection of the number of latent variables
and optimized deﬁnition of control limits and models’ tolerance.
Multivariate statistical control charts based on Hotelling’s T2 and
squared residuals (Q) are often used to monitor the process (Kourti,
2006).
Fig. 1. Structure of a) hydrochlorothiazide (HTZ) and b) p-aminobenzoic acid
(PABA).
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encompassing the batch, process variable and time dimensions.
Multiple methods can be used to analyze three-way arrays without
the need of unfolding (conversion to two-way matrices). Parallel
factor analysis (PARAFAC) (Bro, 1997) or n-way partial least squares
regression (N-PLS) are two methods designed to handle n-way
data (Lopes and Menezes, 2003). However, to analyze data with
PCA or PLS, the three-way matrix needs to be unfolded (Sarraguça
et al., 2010). Unfolding can be done batch-wise (BWU) preserving
the batch direction. Information of one batch is contained in a
single row of the resulting matrix (Souihi et al., 2015). Alterna-
tively, a second type of unfolding, called observation-wise
unfolding (OWU) in which the variable direction is preserved
can be used. For this purpose several methods are available
(Gonzalez-Martinez et al., 2011; Kassidas et al., 1998; Tomasi et al.,
2004; Wold et al., 1998b). There is an important difference
between these two types of unfolding methods. In OWU, the PLS
method using batch time as the response (Y-block) will yield
components that best approximate the average trajectories. In
BWU, the PLS method using a quality attribute of the ﬁnal product
as Y-block will yield components that best capture the variability
among batches. In BSPC, the components of a PLS-OWU model are
rotated to maximize their relationship to batch time or maturity. In
PLS-OWU models, the systematic variation in the predictors (X-
block) that is not related with the batch time can impair the
interpretation of the model (Souihi et al., 2015).
An alternative to PLS regression is the orthogonal partial least
squares (OPLS) method (Trygg and Wold, 2002). OPLS is an
adaptation of the orthogonal signal correction (OSC) method
(Wold et al., 1998a) and differs from PLS by removing systematic
variation in X that is orthogonal to Y. The advantage is to reduce
models’ complexity (by concentrating the predictive information
in one component) and increase interpretability due to the
decreasing of confounding effects stored in model components
(Stenlund et al., 2009).
Since it was ﬁrst proposed in 2002 (Trygg and Wold, 2002) OPLS
and its extensions (e.g. OPLS-DA, K-OPLS, etc.), have been utilized
in distinct contexts for multiple applications (Boccard and
Rutledge, 2013; Rantalainen et al., 2007; Stenlund et al., 2009;
Wiklund et al., 2008). On the other hand, a single application of
OPLS for BSPC has been reported so far (Souihi et al., 2015). The
study in question utilized OPLS for modelling a batch chemical
hydrogenation process comparing it with PLS and PCA. OPLS
demonstrated a superior ability to detect deviations and provided
an easier root cause analysis for these deviations.
Pharmaceutical cocrystals are deﬁned as a multicomponent
crystalline structure formed by one drug substance and one or
more coformers. These compounds have enhanced pharmaceutical
properties such as solubility, bioavailability, stability, among
others (Sarraguca et al., 2014). Cocrystallizations are typically
operated in batch-mode even at the industrial scale. The ability to
monitor on-line the cocrystallization process is relevant to ensure
that the ﬁnal product is consistently delivered within target
speciﬁcations (Sarraguca et al., 2016). This is especially important,
giving the increasingly adopted quality-by-design paradigm for
pharmaceutical processes development framed by the ICH-Q8
guideline (International Conference on Harmonization, 2009).
Previously, PCA-OWU was reported as a BSPC strategy to
monitor on-line the cocrystallization between furosemide and
nicotinamide using near infrared spectroscopy (NIRS) (Sarraguça
et al., 2015). In this work, a cocrystallization process between
hydrochlorothiazide (HTZ) and p-aminobenzoic acid (PABA) by
solvent evaporation was monitored with NIRS. The major aim is to
investigate whether OPLS is consistently more adequate for BSPC
than PLS.2. Experimental
2.1. Materials and methods
HTZ (>98% purity), PABA (>99.5% purity) and methanol (>99.5%
purity) were acquired from Sigma-Aldrich (St. Louis, MO, USA).
Cocrystallization of HTZ and PABA (Fig. 1) was performed by the
solvent evaporation method using methanol. The process consists
on weighting HTZ and PABA followed by dissolution in methanol at
room temperature. The solution is then stirred at 150 rpm, in an
orbital stirring table during 10 h also at room temperature. A total
of nine batches were designed: ﬁve nominal and four abnormal
batches.The operating conditions for the nominal batches were
previously optimized (Sarraguça et al., 2015). From the nominal
batches, four were chosen to calibrate models (B#1–B#4) and one
was used for testing (B#5). The abnormal batches were designed
by imposing multiple disturbances as described in Table 1 (B#8–
B#11).
2.2. On-line monitoring
A Fourier transform near-infrared analyzer (FTLA2000, ABB,
Québec, Canada) was used to monitor on-line the cocrystallization
process. The spectrophotometer is equipped with an indium-
gallium-arsenide (InGaAs) detector. The measurements were
made in diffuse reﬂectance mode using a stainless steel diffuse
reﬂectance probe (SabIR, ThermoNicolet, Madison, USA) with a
1 cm diameter sapphire window enabling a 0.20 cm2 illumination
area. Each spectrum was acquired with a resolution of 8 cm1 over
a wavenumber interval between 10,000 cm1 and 4000 cm1. Each
stored spectrum is an average of 64 scans. The instrument is
controlled via the Grams LT software (version 7, ABB, Québec,
Canada). A background was made before each batch, by placing a
PFTE certiﬁed material (Labsphere North Sutton, NH, USA) over the
probe tip. To monitor the process, the probe was set 1 cm over the
cocrystallization medium in order to avoid interference with the
process. One spectrum was stored every ﬁve minutes during 10 h,
totalizing 121 spectra per batch. All spectra were pre-processed
with the Savitzky-Golay algorithm (29 points width ﬁlter ﬁtted
with a second-order polynomial followed by a ﬁrst derivative) to
reduce unwanted baseline variations and standard normal variate
(SNV) to compensate for scale variations. In total, a three-way array
consisting on 9 batches, 1556 spectral variables and 121 time
points was produced.
2.3. Product characterization
Crystallized products were vacuum dried over 1.5 h to remove
any free residual solvent. The dried products were characterized by
X-ray powder diffraction (XRPD), differential scanning calorimetry
(DSC) and near infrared spectroscopy (NIRS).
Table 1
Summary of the produced cocrystallization batches.
Batches# Methanol (ml) HTZ (mg) PABA (mg) HTZ: PABA (molar ratio) Type of batch Formation of the cocrystal
Calibration B#1–#4 20 416.42 383.58 1:2 Nominal Yes
Test B#5 20 416.42 383.58 1:2 Nominal Yes
B#8 20 416.42 191.79 1:1 Non-nominal No
B#9 15 416.42 383.58 1:2 Non-nominal No
B#10 20 832.84 575.37 2:3 Non-nominal No
B#11 40 416.42 767.16 1:4 Non-nominal Yes
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XRPD analyses were performed on a powder diffractometer
(MINIFlexII, Rigaku, The Woodlands, USA) with Cu Ka radiation
(l = 1.5418 Å) operating at 40 kV/30 mA ﬁtted with a glass sample
holder. Diffraction patterns were obtained with a 0.02 (2u) step
size and 3 s per step in the range 3–45 (2u).
2.3.2. Differential scanning calorimetry
DSC measurements were performed using a thermal analyzer
(DSC 200 F3 Maia1, Netzsch, GmbH, Germany) with an automatic
sample changer (ASC, Netzsch, GmbH, Germany). Approximately
2–3 mg were weighed in aluminum pan and then sealed. The
reference pan was left empty. Heating curves for the samples were
recorded with a heating rate of 10 C min1 from 25 C to 300 C.
The onset temperature was calculated using the software provided
by the DSC equipment (Proteus, version 6.1081, Netzsch, GmbH,
Germany). For each sample, three thermograms were taken and
the average onset temperature considered.Fig. 2. XRPD patterns of the cocrystal obtained in the batch B2.3.3. Near infrared spectroscopy
The same FT-NIR spectroscopy equipment described before was
used off-line for ﬁnal product characterization. The difference was
the use of a powder sampling accessory (ACC101, ABB, Québec,
Canada) featuring a 2 cm diameter window enabling diffuse
reﬂectance measurements on a 0.28 cm2 illumination area. Each
spectrum was acquired with a resolution of 8 cm1 as an average of
64 spectra in the wavenumber range between 10,000 cm1 and
4000 cm1. A background was taken by using a PTFE certiﬁed
material (SKG8613G, ABB, Québec, Canada). For each sample, three
spectral replicates were required and the average spectrum
considered.
2.4. Data analysis
Pre-processed NIR spectra obtained on-line organized in a
three-way matrix (batch x observation x time) was ﬁrstly unfolded
in a two-way structure by means of the OWU approach. After
unfolding, data from batches B#1 to B#4 yielded a two-way#1 and from a physical mixture of HTZ and PABA (PM).
Fig. 3. DSC thermograms for the cocrystal obtained in batch B#1, pure hydrochlorothiazide (HTZ) and pure p-aminobenzoic acid (PABA).
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passing batches B#5 (NOC) and B#8–B#11 (abnormal) were
organized in a (5 121 1556) matrix (testing X-block).Fig. 4. NIR spectra of the cocrystal obtained in batch B#1Two approaches to BSPC were tested considering different
models: PLS and OPLS. The response variable was the batch time
(Y-block). Spectral data (X-block) and the response (Y-block) were and from a physical mixture of HTZ and PABA (PM).
Table 2
Summary of the PLS and OPLS models based on batches B#1–B#4.
Model Component R2X (%) Cumulative R2X
(%)
R2Y (%) Cumulative R2Y
(%)
PLS 1 51.6 51.6 85.5 85.5
2 22.1 73.7 4.5 90.0
OPLS Predictive 48.2 48.2 90.0 90.0
Orthogonal 25.6 73.7 0.0 90.0
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charts were used to detect the deviations from the NOC. Deviations
from the Hotelling’s T2 reveal differences, which can be explained
by the model. “The Hotelling’s T2 statistic for sample j considering a
model with A latent variables is calculated according to Eq. (1).
T2j ¼
XA
a¼1
t2j;a
s2a
ð1Þ
In (Eq. (1)), tj;a is the score for sample j and latent variable a and s
2
a is
the estimate of the variance for the latent variable a. The Q statistic
estimates the distance to model and therefore highlights differ-
ences that cannot be explained by the modelled component
(Eq. (2)).
Qj ¼
XK
k¼1
xj;k  x^j;k
 2 ð2Þ
Where, x^j;iis the data estimation using the model with A
components for sample j and variable k. By monitoring the
residuals, new unexplained disturbances, different from the onesFig. 5. Loadings for PLSin the model, can be detected and action can be taken (Kourti,
2005).
OPLS differs from PLS because it ﬁlters the variation in X
correlated to Y in a single predictive component while variation
uncorrelated to Y is captured in the orthogonal component(s).
Apart from this ﬁltering step, PLS and OPLS models for a single Y
and the same total number of latent variables are identical and
thus the Q statistic for both models is the same. The control charts
were normalized by dividing the Hotelling’s T2 and Q statistics by
their 95% conﬁdence limit. This procedure will lead to a control
limit equal to 1. These two control charts are complementary and
together they give a representation of the system (Kourti, 2006).
The multivariate projection models based on PLS and OPLS were
generated using the SIMCA 14.1 software (MKS Data Analytics
Solutions, Umeå, Sweden).
3. Results
3.1. Final products characterization
The ﬁnal product obtained after each batch was characterized
with XRPD, DSC and NIRS. XRPD patterns of the crystals obtained
from NOC batches and a prepared physical mixture of the initial
components were analyzed to investigate the actual formation of
cocrystals (Fig. 2). The formation a new crystalline form (a possible
cocrystal), is observed by the appearance of non-existing peaks in
the physical mixture, speciﬁcally at 12.9, 14.9, 25.4, 26.0, 27.3,
and 42.0 (2u) marked in the ﬁgure by a dashed line. The proof that
a single crystalline form was obtained was conﬁrmed by DSC. The
thermograms of a NOC batch ﬁnal product and of the initial
components are shown in Fig. 3. The average onset temperature for and OPLS models.
Fig. 6. PLS and OPLS scores for the four calibration batches (batches B#1–B#4).
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remarkably close to that reported by Sanphui et al. of 175.9 C
(Sanphui and Rajput, 2014), and different from the onset
temperature of the two initial components: 268.2  0.71 C for
HTZ and 187.1 0.23 C for PABA. The differences between NIR
spectra of the crystals physical mixture and cocrystals obtained
from the NOC batches are mainly visible in wavenumber regions
associated with primary and secondary amides (around 6950 cm1,
6780 cm1 and between 5000 cm1 and 4450 cm1) (Fig. 4). The
wavenumber region around 5000 cm1 is also associated with the
carboxyl acid group. Other differences are located at 9800 cm1
and 6530 cm1 due to the amine group. From the NIR spectral
analysis it can be established that the groups responsible by
cocrystal hydrogen bonds are the sulphonamide groups of HTZ and
the carboxyl and amide group of PABA as previously reported by
Sanphui et al. (Sanphui and Rajput, 2014).
By combining the information obtained by these techniques, it
can be concluded that the NOC batches produced a single
crystalline phase different from the initial components, therefore
a cocrystal was obtained.
These methods were additionally employed to analyze the
product obtained at the end of the non-nominal batches (B#8–
B#11) revealing that batch B#11 was the only producing a
cocrystal, although with an excess of PABA (Supplementary
material Figs. S1 to S4).3.2. Batch statistical process control
Table 2 summarizes the PLS and OPLS models developed for the
monitoring of the cocrystallization process. The models’ compo-
nents were chosen by maximizing the variance in Y while
minimizing the detection of false deviations (false positives) in
the calibration batches. Two components were ﬁtted on the PLS
model, explaining 90.0% of the variance in Y. The OPLS model also
contains two components, one predictive and one orthogonal. As
expected the overall performance of the models is the same with
the OPLS explaining also 90.0% of the variance in Y. The advantage
in the use of OPLS comes from its capability to partition the
variance in X. Variance in X correlated with Y is retained in the
predictive component and the variance in X uncorrelated with Y is
captured by orthogonal component. Therefore, in the OPLS, the
predictive component explains 90% of the variance in Y and the
orthogonal 0%. The amount of explained variance in X in the ﬁrst
PLS component and in the OPLS predictive component are similar.
In both models, most of the variation related to the process
evolution is already captured by the ﬁrst component.
It can be observed that the loading for the ﬁrst PLS component is
almost equivalent to the same loading obtained with OPLS. The
second PLS component is very similar to the orthogonal compo-
nent of the OPLS model with some exceptions in the region
between 5100 cm1 and 4550 cm1 (Fig. 5).
Fig. 7. Contour plot for the NIR spectra preprocessed with the Savitzky-Golay algorithm (29 points width ﬁlter ﬁtted with a second-order polynomial followed by a ﬁrst
derivative) obtained for a nominal cocrystallization process (batch B#1). A – End of the rapid solvent evaporation; B – Beginning of the cocrystallization; C – End of solvent
evaporation, only cocrystal present.
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similar. In both models, the ﬁrst 100 min (20 spectra) are related
with the rapid evaporation of methanol. The vanishing of the
methyl group bands at 8500 cm1 (Fig. 7) proves this. After
250 min (50 spectra) there is a slight inﬂection on the scores that is
related with the beginning of the appearance of bands related with
the cocrystal, between 5000 cm1 and 4000 cm1 and the
disappearing of methanol related bands at 7000 cm1 (OH
vibration) and 6150 cm1 (methyl group). After 440 min the scores
remain constant which means that the cocrystal is formed and
there is no longer any methanol present.
The scores corresponding to the second PLS component and for
the orthogonal component of OPLS show the evaporation of the
methanol until the bands related with the cocrystal appear after
250 min. After 440 min, the scores remain constant and the
cocrystallization is ﬁnished (Fig. 6). The trajectories of the PLS and
OPLS scores are very similar. The slight differences that can be
observed can be attributed to the fact that while in the PLS model
the information regarding batch evolution is split between the two
components, in the OPLS model the predictive component already
captures all process-related variation (48.2%) ﬁltering the orthog-
onal variation to the second component (25.5%).
BSPC control charts for the Hotelling’s T2 and Q show very
similar trends when considering the four calibration batches.
Additionally, no false positives were detected (Supporting
information Figs. S5 and S6).
Comparing the PLS and OPLS scores for the test batches the
same conclusions can be drawn as for the calibration batches
(Fig. 8). The scores for the ﬁrst PLS component and the scores for
the predictive OPLS component are similar for the ﬁve test batches
as well as the scores for the second PLS component and for the
orthogonal OPLS component. The evolution of batch B#11 is the
most dissimilar in both components compared with the NOC
batches since the scores of both components capture the methanolevaporation and this batch has the highest content of methanol
(40 ml).
In Fig. 9, the Hotelling’s T2 control chart for the test batches for
the PLS and OPLS models is shown. Batch B#5, as expected, is
always below the control limit. However, differences between the
Hotelling’s T2 from the PLS and OPLS models can be seen especially
at the beginning and end of the process. For batch B#8 (molar ratio
of 1:1), after 400 min, i.e., after the solvent evaporated, the process
is out-of-control in the OPLS but not in the PLS control chart. For
this batch, the ﬁnal product is not the cocrystal but a mixture
between HTZ and PABA, so it is expected that the Hotelling’s T2 for
the ﬁnal product will be signaled as out-of-control. The OPLS
model is capable of capturing this deviation while the PLS was not.
Batch B#9 is out-of-control in the beginning of the process in both
PLS and OPLS control charts. This corresponds to the ﬁrst phase of
the process when solvent is evaporating. This batch started with
less solvent (15 ml) than the nominal runs which explains the
deviation. The ﬁnal product of this batch was also a mixture
between the two components and not the cocrystal (Fig. S2).
However, both models failed to detect this deviation in the ﬁnal
part of the process. For batch B#10, the amount of solvent is the
same as in the nominal batches (20 ml), however the initial mass is
higher (molar ratio 2:3), leading to undissolved particles present in
the beginning of the process and therefore to differences in the NIR
spectra due to scattering effects. This effect can be seen in the
Hotelling’s T2 control chart in which the ﬁrst part of the process is
out-of-control for both models. However, in the OPLS case there is
a part of the process’ that is out-of-control (around 500 min of
process time), which is an indication that the ﬁnal product was not
a cocrystal. B#11 has the highest amount of solvent (40 ml) and a
molar ration of 1:4. The batch product was the cocrystal with an
excess of PABA. For both models, out-of-control signals were
detected in the beginning and end of the process, although more
evident for OPLS.
Fig. 8. PLS and OPLS scores for the testing batches (B#5 and B#8–B#11).
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false positives for batches B#8, B#9 and B#10. For the OPLS model,
a false positive was detected for batch B#9. Therefore, it can be
concluded that the two models yield different results for batches
B#8 and B#10 especially at the end, for which the OPLS is above the
95% limit.
The Q control chart (Fig. 10) is the same for both models as for a
single Y the PLS and OPLS models’ solutions are identical. Before
solvent evaporation (400 min), batches B#5 and B#8 are in
control since they have the nominal amount of solvent. Batch B#10
has also the nominal amount of solvent but higher amount of
solids, which lead to a large variation of the NIR spectra leading to
the batch being out of control in the beginning of the process. For
batch B#9 and B#11 both of them had non-nominal amounts of
solvent and therefore are out-of-control in this part of the process.
In the end, only batch B#11 is out-of-control (as it should). This
means that false positives were obtained for batches B#8, B#9 and
B#10.
4. Conclusions
Both PLS and OPLS-based BSPC approaches are suitable to
follow the evolution of the cocrystallization of hydrochlorothiazide
(HTZ) and p-aminobenzoic acid (PABA) monitored with NIR
spectroscopy. Both approaches can detect deviations from normaltrajectory when non-nominal batches are projected into the
model. Regarding the Hotelling’s T2 control chart in the end of the
process the PLS model gave false positives for batches B#8, B#9
and B#10. For the OPLS model, a false positive was obtained for
batch B#9. The main difference between the two models were for
batches B#8 and B#10. The deviations were only detected in the
OPLS model based control charts. OPLS also demonstrated to be
more sensitive to the imposed disturbances. This indicates that the
use of OPLS resulted in an improved Hoteling’s T2 statistic
calculation that allowed a better detection of process disturbances.
The Q control chart is the same for both models so no
comparison can be made. However, this chart shows differences
mainly in the beginning of the process before the solvent complet
eevaporation. Towards the process end, the Q control chart shows
false positives for B#8, B#9 and B#10.
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